Unter den Marken unserer mehr als 25 Partner sticht TargetMol hervor
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Endet am 31. Dez.( 8 verbleibende Tage )
GNE-2256
CAS:GNE-2256, also known as molecule 19, is an orally active compound that inhibits Interleukin 1 receptor-associated kinase 4 (IRAK4) with a K i of 1.4 nM and hasFormel:C24H27FN6O4Farbe und Form:SolidMolekulargewicht:482.51TP-030-2
CAS:<p>TP-030-2 is a RIPK1 inhibitor (human K i =0.43 nM ; mouse IC 50 =100 nM) .</p>Formel:C23H21BrN4O3Farbe und Form:SolidMolekulargewicht:481.34TP-030-1
CAS:TP-030-1, RIPK1 inhibitor: K(i) hRIPK1 at 3.9nM, IC50 mRIPK1 at 4.2μM; targets inflammation, neurodegeneration research.Formel:C23H22N4O3Farbe und Form:SolidMolekulargewicht:402.45CK2-IN-4
CAS:<p>CK2-IN-4 is a protein kinase (CK2) inhibitor with an IC50 value of 8.6 µM.</p>Formel:C18H11N3O4SReinheit:99.72%Farbe und Form:SolidMolekulargewicht:365.36IGUANA-1
CAS:<p>IGUANA-1 is a highly efficient and selective ALDH1B1 inhibitor that inhibits the growth of colorectal cancer cells and colorectal cancer cell-derived organoids.</p>Formel:C27H26ClN3O4Reinheit:99.08%Farbe und Form:SolidMolekulargewicht:491.97MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Formel:C19H17ClFN7O2SFarbe und Form:SolidMolekulargewicht:461.9TMV-IN-1
CAS:TMV-IN-1: a chalcone inhibits TMV with EC50s of 70.7 and 60.8 μg/mL, applicable in infection and tumor studies.Formel:C28H26O4Farbe und Form:SolidMolekulargewicht:426.5DHBP dibromide
CAS:DHBP dibromide (1,1'-DI-N-HEPTYL-4,4'-BIPYRIDINIUM DIBRO) is calcium release and a muscle relaxant inhibitor.Formel:C24H38Br2N2Reinheit:99.73%Farbe und Form:Yellow To Yellow-Green Powder Or FlakesMolekulargewicht:514.38CK2-IN-6
CAS:CK2-IN-6: Potent CK2 inhibitor for cancer, inflammation, pain, and immune research.Formel:C19H16ClN7O2Farbe und Form:SolidMolekulargewicht:409.83BGB-8035
CAS:<p>BGB-8035 is a BTK inhibitor with antitumor activity that inhibits BTK, TEC, and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.</p>Formel:C24H31N5O4Reinheit:96.74%Farbe und Form:SolidMolekulargewicht:453.53SZM-1209
CAS:<p>SZM-1209 is a potent and specific RIPK1 inhibitor with oral activity, displaying a dissociation constant (Kd) of 85 nM.</p>Formel:C31H29F5N4O5S2Reinheit:98%Farbe und Form:SolidMolekulargewicht:696.71GLPG3970
CAS:GLPG3970, a pioneering inhibitor of SIK2/SIK3, is utilized in the investigation of inflammation and autoimmune diseases.Formel:C25H27F3N4O4Reinheit:99.60% - >99.99%Farbe und Form:SolidMolekulargewicht:504.5DKFZ-748
CAS:<p>DKFZ-748 is a selective HDAC10 inhibitor and has a dose-dependent growth inhibitory effect on HeLa cells.</p>Formel:C18H23N3O3Reinheit:98.10%Farbe und Form:SolidMolekulargewicht:329.39RGT-068A
CAS:RGT-068A is a potent, selective and oral bioavailable MALT1 inhibitor .Formel:C17H16ClN9O2Farbe und Form:SolidMolekulargewicht:413.82DHBP
CAS:DHBP (Benzoresorcinol) is an WalKR TCS activator.Formel:C13H10O3Reinheit:99.95%Farbe und Form:Light-Yellow Solid CrystallineMolekulargewicht:214.22Angiotensin (1-7)
CAS:Angiotensin (1-7) (ASP-ARG-VAL-TYR-ILE-HIS-PRO) is a synthetic heptapeptide, inhibits canine ACE activity with vasodilator and antiproliferative activities.Formel:C41H62N12O11Reinheit:>99.99%Farbe und Form:White Lyophilised SolidMolekulargewicht:899I-BET432
I-BET432, a BET inhibitor, blocks BRD4 BD1/BD2 (pIC50: 7.5/7.2), is oral, and targets cancer/inflammation.Formel:C18H21N3O3Farbe und Form:SolidMolekulargewicht:327.38BLM-IN-2
BLM-IN-2: BLM inhibitor, IC50=0.8 μM; hinders CRC cell growth, invasion, cycle arrest, and death.Formel:C33H38BrFN4OFarbe und Form:SolidMolekulargewicht:605.58TUL01101
CAS:<p>TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.</p>Formel:C22H25F2N5O2Farbe und Form:SolidMolekulargewicht:429.46BAY-7081
BAY-7081 is a cyanopyridone-based compound that functions as a potent, selective, and orally active PDE9A inhibitor, demonstrating an inhibition concentration (Formel:C19H27ClN4OFarbe und Form:SolidMolekulargewicht:362.9ASPER-29
CAS:ASPER-29, an Asperphenamate analog, inhibits cathepsins L/S with IC50s of 6.03/5.02 μM, useful in cancer migration/invasion research.Formel:C31H29BrN2O5SFarbe und Form:SolidMolekulargewicht:621.54ARS-2102
CAS:ARS-2102 is a potent covalent KRAS G12C inhibitor for use in cancer research .Formel:C28H31ClF2N6O2Farbe und Form:SolidMolekulargewicht:557.03ENT-C225
CAS:ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.Formel:C26H40N4O5Reinheit:99.36% - 99.36%Farbe und Form:SolidMolekulargewicht:488.62FTX-6746
CAS:FTX-6746 is an orally active and selective PPARG reverse inhibitor with anticancer activity. It can be used in research on urothelial carcinoma.Formel:C16H7ClF2N2OReinheit:98.68%Farbe und Form:SolidMolekulargewicht:316.695'-N-Ethylcarboxamidoadenosine
CAS:<p>NECA, an adenosine receptor agonist, boosts brain extravasation of fluorescein and dextran without affecting the blood-brain barrier.</p>Formel:C12H16N6O4Reinheit:98.95% - ≥95%Farbe und Form:PowderMolekulargewicht:308.29PG-11047
CAS:PG-11047 (CGC-11047) is a polyamine analogue utilized in breast cancer research.Formel:C14H32N4Farbe und Form:SolidMolekulargewicht:256.43PG-11047 2HCl
PG-11047 2HCl treats genitourinary, immune, genetic, ocular, blood/lymphatic disorders, and aids lymphoma/prostate cancer research.Formel:C14H34Cl2N4Reinheit:97.47%Farbe und Form:SolidMolekulargewicht:329.35Debneyol
CAS:Debneyol exhibits more potent fungicidal activity than validamycin.Formel:C15H26O2Farbe und Form:SolidMolekulargewicht:238.37Flavipin
CAS:Flavipin: Ahr agonist, alters Ahr genes in T cells/macrophages, disrupts Arid5a, scavenges DPPH (IC50=7.2μM), inhibits α-glucosidase (IC50=33.8μM).Formel:C9H8O5Farbe und Form:SolidMolekulargewicht:196.16Aviculin
CAS:Aviculin, a lignan glycoside, exhibits anticancer properties by inducing apoptosis in breast cancer cells with an IC50 of 75.47 μM.Formel:C26H34O10Farbe und Form:SolidMolekulargewicht:506.54JNJ-9350
CAS:<p>JNJ-9350: SMOX inhibitor (IC50 0.01 μM), PAO inhibitor (IC50 0.79 μM), for cancer research.</p>Formel:C25H22N6OFarbe und Form:SolidMolekulargewicht:422.48Immepip
CAS:Immepip, a H3 agonist, has been shown to attenuate cortical histamine release and is utilized in the research of neurological diseases.Formel:C9H15N3Farbe und Form:SolidMolekulargewicht:165.24SBI-993
CAS:SBI-993 is a potent SBI-477 analog with good pharmacokinetics and enhances insulin signaling by inhibiting MondoA.Formel:C23H24N4O4SFarbe und Form:SolidMolekulargewicht:452.53Diclofensine
CAS:<p>Diclofensine (Ro 8-4650) inhibits the uptake of serotonin, noradrenaline and dopamine.</p>Formel:C17H17Cl2NOReinheit:97.01% - 98.13%Farbe und Form:SolidMolekulargewicht:322.23MK-4541
CAS:MK-4541: oral, selective AR modulator, blocks 5α-reductase, curbs AR+ prostate cancer growth, effective in mouse model.Formel:C22H31F3N2O3Farbe und Form:SolidMolekulargewicht:428.49PV-1019
CAS:PV-1019 (NSC 744039), a potent Chk2 inhibitor, has an IC50 of 24 nM and blocks Chk2 autophosphorylation and IR-induced apoptosis.Formel:C18H17N7O3Farbe und Form:SolidMolekulargewicht:379.37Cadein1
Cadein1, an isoquinolinium derivative, induces G2/M phase delay and caspase-dependent apoptosis in cancer cells lacking functional p53.Formel:C33H48F2INO2Farbe und Form:SolidMolekulargewicht:655.64EDP-305
CAS:<p>EDP-305, an oral FXR agonist, has EC50s of 34 nM/8 nM in CHO/HEK cells, aids in PBC and NASH research with antifibrotic properties.</p>Formel:C36H58N2O5SFarbe und Form:SolidMolekulargewicht:630.92Miclxin
CAS:Miclxin (DS37262926) is a novel MIC60 inhibitor that induces apoptosis through mitochondrial stress in mutant tumor cells via β-catenin.Miclxin is a potentFormel:C26H27N5O2Reinheit:99.17% - 99.99%Farbe und Form:SolidMolekulargewicht:441.52BiCAPPA
CAS:BiCAPPA, a bivalent antiprion, reduces scrapie-infected prion proteins with 0.32 μM efficiency.Formel:C38H40Cl2N6O2Farbe und Form:SolidMolekulargewicht:683.67Con B-1
CAS:ConB-1 is a potent and selective ALK inhibitor with low toxicity to normal cells .Formel:C38H52ClN7O6SFarbe und Form:SolidMolekulargewicht:770.38JMX0293
<p>JMX0293, a salicylamide derivative, inhibits STAT3, inducing MDA-MB-231 cell apoptosis with IC50=3.38μM, while sparing MCF-10A (IC50>60μM).</p>Formel:C25H30Cl2N4O7Farbe und Form:SolidMolekulargewicht:569.43BM212
CAS:BM212 is an antimycobacterial compound.It inhibits the growth of laboratory and clinical isolate M. tuberculosis strains.Formel:C23H25Cl2N3Reinheit:99.13%Farbe und Form:SolidMolekulargewicht:414.37SP-471P
CAS:SP-471P inhibits DENV protease; EC50: DENV1-5.9 μM, DENV2-1.4 μM, DENV3-5.1 μM, DENV4-1.7 μM; CC50 >100 μM; lowers viral RNA synthesis.Formel:C33H26BrN5O2Farbe und Form:SolidMolekulargewicht:604.5CPT-Se3
CAS:CPT-Se3, a camptothecin derivative, boosts anticancer activity, triggers apoptosis in Hep G2, and is cytotoxic to various cells with IC50 of 2.19-4.7 μM.Formel:C24H20N2O6Se2Reinheit:98%Farbe und Form:SolidMolekulargewicht:590.35CPT-Se4
CAS:CPT-Se4, a seleno-derivative of CPT, effectively kills cancer cells, triggers apoptosis, and is cytotoxic against various cell lines.Formel:C25H24N2O7Se2Reinheit:98%Farbe und Form:SolidMolekulargewicht:622.39GA-O-02
GA-O-02, an 18β-Glycyrrhetinic acid derivative, inhibits NO/cytokines and fights Gram-positive bacteria; potent anti-inflammatory/antimicrobial.Formel:C37H46ClNO6Farbe und Form:SolidMolekulargewicht:636.22GA-O-06
GA-O-06: 18β-Glycyrrhetinic acid derivative with powerful antimicrobial effects on Gram-positive bacteria and anti-inflammatory properties.Formel:C37H46FNO6Farbe und Form:SolidMolekulargewicht:619.76CFT8634
CAS:CFT8634 degrades BRD9, for synovial sarcoma and SMARCB1 tumor research, from patent WO2021178920A1.Formel:C37H45F3N6O5Farbe und Form:SolidMolekulargewicht:710.79VT02956
CAS:<p>VT02956 inhibits LATS1 (IC50: 0.76 nM) & LATS2 (0.52 nM), targets Hippo pathway, and hampers ER+ breast cancer growth.</p>Formel:C22H23N5OFarbe und Form:SolidMolekulargewicht:373.45PF-04979064
CAS:<p>PF-04979064 is a potent and selective PI3K and mTOR dual kinase inhibitor(Ki of 0.13 nM and 1.42 nM,respectively).</p>Formel:C24H26N6O3Reinheit:98.20% - ≥98%Farbe und Form:SolidMolekulargewicht:446.5KFU-127
KFU-127: broad-spectrum antimicrobial; targets bacterial/fungal biofilms; toxic to eukaryotic cells.Formel:C34H43BrN2O3Farbe und Form:SolidMolekulargewicht:607.62BAY-390
CAS:BAY-390, a selective TRPA1 inhibitor, crosses species, penetrates brains, with IC50s: 16-82 nM. Used in inflammation research.Formel:C13H15F4NOFarbe und Form:SolidMolekulargewicht:277.26MS47134
MS47134: potent MRGPRX4 agonist, EC50 = 149 nM, for pain/itch/hypersensitivity research.Formel:C22H29NO3Farbe und Form:SolidMolekulargewicht:355.47BI-2081
CAS:<p>BI-2081: GPR40 agonist, EC50=4nM, boosts insulin, lowers blood glucose, potential for type 2 diabetes research.</p>Formel:C32H35FO6Farbe und Form:SolidMolekulargewicht:534.62BI-2540
CAS:<p>BI-2540 is a HIV non-nucleoside reverse transcriptase ( NNRT ) inhibitor .</p>Formel:C24H15ClF5NO5Farbe und Form:SolidMolekulargewicht:527.83AK-IN-1
CAS:AK-IN-1: competitive adenosine inhibitor, not ATP; inhibits AK 86-89% at 2-10 µM; promising for ischaemia, inflammation, seizure research.Formel:C22H21N3O4Farbe und Form:SolidMolekulargewicht:391.42DP00477
CAS:DP00477, a potent inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), exhibits an inhibitory concentration (IC50) of 7.0 µM.Formel:C17H11ClF3N3OSFarbe und Form:SolidMolekulargewicht:397.8MK-3402
CAS:<p>MK-3402 is a metallo-beta-lactamase inhibitor. MK-3402can be used in the research of bacteria .</p>Formel:C15H19N9O5S2Farbe und Form:SolidMolekulargewicht:469.50MPH-220
CAS:MPH-220: Oral myosin-2 inhibitor, induces muscle relaxation, useful for spasticity research.Formel:C20H21N3O3SFarbe und Form:SolidMolekulargewicht:383.46SDMA
CAS:<p>SDMA (Symmetric dimethylarginine) is the most potent endogenous inhibitor of nitric oxide synthase (NOS), with higher levels in patients with end-stage renal</p>Formel:C8H18N4O2Reinheit:95.74% - ≥98%Farbe und Form:SolidMolekulargewicht:202.25ccc_R08
CAS:<p>ccc_R08 is an HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg. ccc_R08 may be investigated in HBV infections.</p>Formel:C22H19ClO6Reinheit:99.45% - 99.86%Farbe und Form:SoildMolekulargewicht:414.84TBI-166
CAS:TBI-166, an oral riminophenazine, treats tuberculosis with fewer side effects than Clofazimine.Formel:C32H30F3N5O3Farbe und Form:SolidMolekulargewicht:589.61KM04416
CAS:<p>KM04416 is a GPD2 inhibitor that inhibits LUAD progression by modulating immune cell infiltration.</p>Formel:C12H11NO3SReinheit:99.88%Farbe und Form:SolidMolekulargewicht:249.29STL1267
CAS:STL1267 is a REV-ERB agonist that crosses the blood-brain barrier and inhibits BMAL1 gene expression.Formel:C17H11ClN4OReinheit:99.19%Farbe und Form:SolidMolekulargewicht:322.75BRD7586
CAS:BRD7586 is a cell-permeable small molecule inhibitor of SpCas9 that enhances SpCas9 specificity.Formel:C17H14ClN3O3S2Reinheit:97.70% - 99.03%Farbe und Form:SolidMolekulargewicht:407.89TIM-063
CAS:TIM-063: ATP-competitive CaMKKα/β inhibitor, cell-permeable, Ki: 0.35/0.2 μM, IC50: 0.63/0.96 μM.Formel:C18H9N3O4Farbe und Form:SolidMolekulargewicht:331.28BI-3231
CAS:<p>BI-3231 is a hydroxysteroid 17ß-dehydrogenase 13 HSD17B13 inhibitor that inhibits hHSD17B13 .BI-3231 can be used to study cirrhosis.</p>Formel:C16H14F2N4O3SReinheit:98.2%Farbe und Form:SolidMolekulargewicht:380.37NP10679
CAS:NP10679 is a N-methyl-D-aspartate (NMDA) receptor inhibitor of the GluN2B subunit that inhibits histamine H1, hERG channels, and CYPase.Formel:C23H26F3N3O3Reinheit:99.43%Farbe und Form:SolidMolekulargewicht:449.47CZS-241
CZS-241: Oral PLK4 inhibitor (IC50=2.6 nM), less potent TRKA blocker (IC50=2.74 μM), triggers apoptosis and S/G2 arrest, anti-leukemia, safe for normal cells.Formel:C26H24ClF2N9OFarbe und Form:SolidMolekulargewicht:551.987-Hydroxy-4H-chromen-4-one
CAS:7-Hydroxy-4H-chromen-4-one (7-hydroxy-4-benzopyrone) is a Src kinase inhibitor (IC50 of <300 μM).Formel:C9H6O3Reinheit:97.65%Farbe und Form:SolidMolekulargewicht:162.14TH-Z145
CAS:<p>TH-Z145 is a potent FPPS inhibitor for the study of myeloma and lung cancer.</p>Formel:C16H28O7P2Reinheit:98.29%Farbe und Form:SolidMolekulargewicht:394.34BAY-364
CAS:BAY-364 (BAY-299N) functions as an inhibitor targeting the second bromine domain in TAF1, demonstrating inhibitory effects on TAF1 in Kasumi-1 cells, CD34+Formel:C23H19N3O4Farbe und Form:SolidMolekulargewicht:401.41MRS4596
MRS4596: selective P2X4 blocker, IC50 1.38 μM, neuroprotective in stroke research.Formel:C21H14N5NaO3SFarbe und Form:SolidMolekulargewicht:439.42MRS4719
CAS:<p>MRS4719: potent P2X4 antagonist, IC50 0.503 μM. Reduces infarct, brain atrophy, Ca2+ influx. Used in ischemic stroke research.</p>Formel:C26H13N5O3S·C6H15NFarbe und Form:SolidMolekulargewicht:504.6SAHA-OH
CAS:<p>SAHA-OH selectively inhibits HDAC6 (IC50 = 23 nM) with 10-47x preference over HDACs 1, 2, 3, 8, and reduces inflammation and macrophage apoptosis.</p>Formel:C15H22N2O4Reinheit:98%Farbe und Form:SolidMolekulargewicht:294.35Ph-HTBA
CAS:Ph-HTBA: high-affinity CaMKIIα modulator, brain-penetrant, Kd 757 nM, used in ischemia/neurodegeneration research.Formel:C19H18O3Farbe und Form:SolidMolekulargewicht:294.34DRP1i27
CAS:DRP1i27 inhibits human Drp1 at GTPase site, prevents mitochondrial fission, and shields cells from ischemia-reperfusion damage.Formel:C20H26N6OFarbe und Form:SolidMolekulargewicht:366.46DN-1289
<p>DN-1289: oral, BBB-penetrating, selectively inhibits DLK (IC50=17nM) & LZK (IC50=40nM), blocks p-c-Jun in mouse optic nerve crush.</p>Formel:C18H19F4N7O2Reinheit:98.56%Farbe und Form:SolidMolekulargewicht:441.38LWG-301
LWG-301, a GLS1 allosteric inhibitor, IC50 7 nM, impedes glutamine metabolism and prompts apoptosis; shows antitumor effects.Formel:C28H38N8O3SFarbe und Form:SolidMolekulargewicht:566.72DS-9300
CAS:DS-9300, an orally administered potent and selective inhibitor of EP300/CBP HAT, exhibits a significant inhibitory activity with an IC50 value of 28 nM.Formel:C25H26F3N5O3Farbe und Form:SolidMolekulargewicht:501.50Lodenafil
CAS:Lodenafil (Hydroxyhomosildenafil) is a potent PDE5 inhibitor, with treatment of erectile dysfunction (ED)Formel:C23H32N6O5SReinheit:99.92%Farbe und Form:SolidMolekulargewicht:504.6DDO3711
CAS:"DDO3711, a PHORC, links an ASK1 inhibitor to a PP5 activator, inhibiting ASK1 (IC50=164.1 nM), dephosphorylating p-ASK1, and showing anti-cancer potential."Formel:C42H41N9O6Farbe und Form:SolidMolekulargewicht:767.83BAY-805
CAS:BAY-805, a selective USP21 inhibitor, targets DUBs with high specificity.Formel:C24H28F3N5O2SReinheit:99.49%Farbe und Form:SolidMolekulargewicht:507.57MK-8189
CAS:MK-8189 is a potent and selective pyrimidine PDE10A inhibitor, with excellent PDE (phosphodiesterase) selectivity for the treatment of schizophrenia.Formel:C19H22N6OSReinheit:99.38% - 99.67%Farbe und Form:SolidMolekulargewicht:382.48(1R,2R)-MK-8189
CAS:(1R,2R)-MK-8189 is an isomer of MK-8189, a potent and selective pyrimidine PDE10A inhibitor.Formel:C19H22N6OSReinheit:>99.99% - >99.99%Farbe und Form:SoildMolekulargewicht:382.48NX-2127
CAS:NX-2127 (ETX2514 Triethylamine) is an orally active BTK inhibitor that induces degradation of mutant BTKC481S in cells.NX-2127 has potent antiproliferativeFormel:C39H45N9O5Reinheit:99.07%Farbe und Form:SolidMolekulargewicht:719.83TYA-018
CAS:<p>TYA-018 is an HDAC6 inhibitor with cardioprotective effects and is used in the study of dilated heart disease and heart failure.</p>Formel:C15H13ClF2N4O3S2Reinheit:98.64%Farbe und Form:SolidMolekulargewicht:434.87Goitrin
CAS:<p>Goitrin, from glucosinolate reactions, blocks thyroid peroxidase and iodine use, and fights H1N1.</p>Formel:C5H7NOSFarbe und Form:SolidMolekulargewicht:129.18Pulixin
CAS:Pulixin blocks FREP1 from P. falciparum, hinders parasite spread (EC50: 11µM), and stops its growth (EC50: 47nM).Formel:C14H11NO4Farbe und Form:SolidMolekulargewicht:257.24SG2057
CAS:<p>SG2057 (DRG16), a PBD dimer with pentyldioxy linkage, binds DNA minor groove, forms cross-links, and is a potent antitumor agent.</p>Formel:C33H36N4O6Farbe und Form:SolidMolekulargewicht:584.66CU-CPT-8m
CAS:<p>CU-CPT-8m (TLR8-specific antagonist) is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM)</p>Formel:C14H12N4OReinheit:99.00%Farbe und Form:SolidMolekulargewicht:252.27PF-184
PF-184: potent IKK-2 inhibitor, selective over 30+ kinases; useful for asthma & COPD research. IC50: 37 nM.Formel:C32H32ClFN6O4Farbe und Form:SolidMolekulargewicht:619.09YLT-11
<p>YLT-11: Oral PLK4 inhibitor, Kd 5.2 nM; less effective on PLK1/2/3; inhibits cancer cell growth and induces G2/M arrest and apoptosis.</p>Formel:C24H24N6OFarbe und Form:SolidMolekulargewicht:412.49Erasin
Erasin is a STAT3 inhibitor induces apoptosis in various cancer cell lines (e.g., MDA-MB-231, HCC-827) and against Erlotinib-resistant cancer cells.Formel:C20H19N3O3Farbe und Form:SolidMolekulargewicht:349.38TPN729
CAS:TPN729, a PDE5 inhibitor, has an IC50 of 2.28 nM, used to research erectile dysfunction.Formel:C25H36N6O4SFarbe und Form:SolidMolekulargewicht:516.66SMN-C2
CAS:<p>SMN-C2, a SMN2 gene splicing regulator, is an RNA-binding ligand that regulates pre-mRNA splicing and has potential for studying spinal muscular atrophy.</p>Formel:C24H27N5O2Reinheit:99.14%Farbe und Form:SolidMolekulargewicht:417.5YC-001
CAS:YC-001: inverse agonist/antagonist for rod opsin, prevents light-induced retinal degeneration.Formel:C12H7ClO2S2Farbe und Form:SolidMolekulargewicht:282.77SHP844
CAS:SHP844: SHP2 inhibitor, IC50 18.9 µM, affects cell growth/survival by regulating tyrosine phosphorylation.Formel:C29H24ClN5O6Farbe und Form:SolidMolekulargewicht:573.98ME-143
CAS:ME-143, a 2nd-gen NADH oxidase inhibitor, blocks WNT/β-catenin pathway, active against various cancers in vitro/vivo.Formel:C21H18O4Farbe und Form:SolidMolekulargewicht:334.37
